Beyond the Building: The Medical-Equipment Lifecycle and the Commissioning Record
When a hospital project finishes, attention moves on. The building is open, the ribbon is cut, and the capital file is treated as closed. Inside the building, though, a second and much longer capital story is only starting. Thousands of clinical devices - imaging systems, monitors, pumps, sterilizers, lab analyzers - have just been installed, and each one begins a lifecycle of its own: acceptance testing and commissioning, calibration, preventive maintenance, software and safety upgrades, recalls, and eventually planned replacement. That lifecycle typically outlasts the project team, the vendor's account manager, and often the software the records were first kept in.
The result is a familiar gap. A health authority can usually say what it owns and roughly what it paid. It is much harder to say, for a specific device on a specific unit, what the acceptance testing showed at handover, which conditions were left outstanding and whether they were closed, what the warranty and service contract actually cover, which upgrades and recalls have been applied, and when replacement is funded. Those answers sit in a biomedical engineering system, a vendor's portal, a facilities work-order tool, a procurement folder and a commissioning consultant's binder. Individually each is fine. Collectively they are not a record - and the questions that arrive, from a board, a regulator, a coroner or an insurer, are almost always about one device on one day.
Recent context
Equipment is a growing share of health capital, not a footnote to construction. Statistics Canada reported in June 2026 that capital expenditures in health care and social assistance are projected at $20.7 billion for 2026 - $16.3 billion of it construction and $4.4 billion machinery and equipment - up from $13.5 billion in 2022, an average annual increase of 7.4 per cent. The same analysis notes how much of that growth is absorbed by prices rather than capacity: machinery and equipment prices rose 19.7 per cent between 2020 and 2024, and a hospital wing costing $100 million in 2020 would have cost roughly $128 million to build in 2024. When more than four billion dollars a year goes into devices, the lifecycle record behind those devices stops being a technical detail.
Commissioning is where the record is made or lost
Commissioning is the handover moment when a device stops being a purchase and becomes a clinical asset. It is also the point where the evidence is either captured or quietly abandoned. Acceptance testing results, calibration baselines, deficiency lists and their closure, staff training completion, integration testing with clinical systems, and the warranty start date all exist on that day and are difficult to reconstruct afterwards. When commissioning documentation stays with the installing vendor or the consultant who ran the handover, the health authority ends up owning the device without owning its provenance. Years later that shows up in ordinary ways: a service dispute where nobody can produce the accepted baseline, a replacement plan that cannot be defended to a board because the true in-service date is unclear, or an incident review that needs the maintenance history and finds it split across two systems and a retired technologist's spreadsheet.
How XNM helps
XNM helps health authorities and hospital boards bring the equipment lifecycle record into one governed, auditable place alongside the rest of the capital file - purchase and warranty terms, commissioning and acceptance documentation, deficiency closeout, service contracts, upgrade and recall actions, and the replacement plan and its funding approvals, organized by asset and by site. Where it fits, the XNM-Vision platform gives a capital team and a board one line of sight across devices and projects at once, so a service dispute, a replacement request or an incident review is answered from a complete, time-stamped record rather than a search across systems. It does not replace a biomedical maintenance system or perform commissioning; it makes sure the owner's evidence of what was accepted, promised and maintained survives the vendors, the software and the staff turnover.
Practical takeaways
Take custody of commissioning evidence on the day it exists. Acceptance results, calibration baselines and deficiency lists are cheap to keep at handover and nearly impossible to recreate two years later.
Track deficiencies to closure, not to a list. An outstanding item at handover only matters if someone can later show whether it was resolved, by whom, and when.
Keep warranty and service terms with the asset. The contract that governs a device is the first thing needed in a dispute and the last thing anyone can find when it lives in a procurement folder.
Make replacement planning evidence-based. A board can approve a replacement programme far more confidently when in-service dates, service history and condition are attached to each unit.
Assume the record will outlive the system it was born in. Devices run for a decade or more; plan for the vendor portal, the maintenance software and the staff who set it up all changing at least once.
FAQ
Our biomedical engineering team already maintains an asset database. Is that not the record?
It is an essential part of it, and it is usually strong on maintenance. What tends to be missing is everything from the front and back of the lifecycle: the commissioning and acceptance package, the deficiency closeout, the contractual warranty and service terms, and the capital approvals behind replacement. Those live outside the maintenance system, and they are what a board, an insurer or a regulator asks about. The goal is not to replace the asset database but to make sure it is not the only surviving evidence.
Equipment is bought project by project. Should the record follow the project or the device?
The device. Projects end; assets persist, and they get moved, redeployed and upgraded across sites long after the project that bought them is closed. Keeping the record asset-first means the file follows the machine that is actually in clinical use, while still linking back to the project, the funding source and the approvals that put it there.
The bottom line
The building opens once; the equipment inside it is bought, accepted, maintained and replaced continuously for decades. Treating commissioning as the end of the capital file is what makes the next twenty years harder than they need to be. Capture the evidence at handover and the lifecycle answers itself.
